2023 | Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected Patients | YU-SHAN HUANG ; Cheng, Chien-Yu; HSIN-YUN SUN ; Cheng, Shu-Hsing; Lu, Po-Liang; Lee, Chen-Hsiang; Lee, Yuan-Ti; Tsai, Hung-Chin; Yang, Chia-Jui; Liu, Chun-Eng; Liou, Bo-Huang; Lin, Shih-Ping; Huang, Sung-Hsi; Ho, Mao-Wang; Tang, Hung-Jen; CHIEN-CHING HUNG | Microbiology spectrum | 0 | 0 | |